Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bioactive oligosaccharides are short-chain carbohydrates, typically consisting of three to ten monosaccharide units, that exert specific biological effects beyond their basic nutritional value. These molecules are found naturally in diverse sources such as human milk (HMOs), plants, and honey, or they can be produced via enzymatic synthesis for use in functional foods and pharmaceuticals (Kunz et al., 2000; Mussig et al., 2021). Their biological roles are vast, including the promotion of beneficial gut microbiota, such as Bifidobacteria, and the inhibition of pathogen adhesion by mimicking the glycan structures found on human intestinal surfaces (Bode, 2012). In clinical contexts, they are investigated for their ability to modulate the immune system, reduce systemic inflammation, and prevent necrotizing enterocolitis or other infectious diseases (Slavin, 2013). However, 'Bioactive oligosaccharides' is a broad chemical classification rather than a specific therapeutic target molecule like a protein or receptor. While specific oligosaccharides like fondaparinux are used as drugs to target proteins like antithrombin, the category as a whole refers to a heterogeneous group of bioactive ligands and dietary fibers.
Bioactive oligosaccharides function as therapeutic ligands or nutritional supplements rather than targets; they act by promoting the growth of beneficial gut bacteria (prebiotic effect), serving as soluble decoy receptors that prevent pathogen binding to host cell surfaces, and modulating immune cell activity through interaction with carbohydrate-binding proteins like lectins.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bioactive oligosaccharide.